Clinical Trial Update: A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer [Phase 2]

View source ↗

Summary

This update indicates that the Phase II trial evaluating early medical adrenalectomy for prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED